...
首页> 外文期刊>Nanotechnology >Mn-doped Zinc Sulphide nanocrystals for immunofluorescent labeling of epidermal growth factor receptors on cells and clinical tumor tissues
【24h】

Mn-doped Zinc Sulphide nanocrystals for immunofluorescent labeling of epidermal growth factor receptors on cells and clinical tumor tissues

机译:锰掺杂的硫化锌纳米晶体用于免疫荧光标记细胞和临床肿瘤组织上的表皮生长因子受体

获取原文
获取原文并翻译 | 示例
           

摘要

The field of molecular detection and targeted imaging has evolved considerably with the introduction of fluorescent semiconductor nanocrystals. Manganese-doped zinc sulphide nanocrystals (ZnS:Mn NCs), which are widely used in electroluminescent displays, have been explored for the first time for direct immunofluorescent (IF) labeling of clinical tumor tissues. ZnS:Mn NCs developed through a facile wet chemistry route were capped using amino acid cysteine, conjugated to streptavidin and thereafter coupled to biotinylated epidermal growth factor receptor (EGFR) antibody utilizing the streptavidin–biotin linkage. The overall conjugation yielded stable EGFR antibody conjugated ZnS:Mn NCs (EGFR ZnS:Mn NCs) with a hydrodynamic diameter of 65 ± 15 nm, and having an intense orange–red fluorescence emission at 598 nm. Specific labeling of EGF receptors on EGFR~(+ve) A431 cells in a co-culture with EGFR~(?ve) NIH3T3 cells was demonstrated using these nanoprobes. The primary antibody conjugated fluorescent NCs could also clearly delineate EGFR over-expressing cells on clinical tumor tissues processed by formalin fixation as well as cryopreservation with a specificity of 86% and accuracy of 88%, in comparison to immunohistochemistry. Tumor tissues labeled with EGFR ZnS:Mn NCs showed good fluorescence emission when imaged after storage even at 15 months. Thus, ZnS nanobioconjugates with dopant-dependent and stable fluorescence emission show promise as an efficient, target-specific fluorophore that would enable long term IF labeling of any antigen of interest on clinical tissues.
机译:随着荧光半导体纳米晶体的引入,分子检测和靶向成像领域已经有了长足发展。锰掺杂的硫化锌纳米晶体(ZnS:Mn NCs)被广泛用于电致发光显示器中,首次被用于临床肿瘤组织的直接免疫荧光(IF)标记。 ZnS:Mn NCs通过一种简便的湿化学方法开发,使用氨基酸半胱氨酸加帽,与抗生蛋白链菌素结合,然后利用抗生蛋白链菌素-生物素键联至生物素化的表皮生长因子受体(EGFR)抗体。总体偶联产生稳定的EGFR抗体偶联的ZnS:Mn NCs(EGFR ZnS:Mn NCs),其流体动力学直径为65±15 nm,并在598 nm处发出强烈的橙红色荧光。使用这些纳米探针证明了在与EGFR〜(ve)NIH3T3细胞共培养中EGFR〜(ve)A431细胞上EGF受体的特异性标记。与免疫组化相比,与荧光抗体结合的一抗荧光NC还可以清楚地描述在福尔马林固定和冷冻保存后临床肿瘤组织上EGFR过表达的细胞,特异性为86%,准确度为88%。当保存15个月后成像时,标有EGFR ZnS:Mn NCs的肿瘤组织显示出良好的荧光发射。因此,具有依赖于掺杂剂的稳定荧光发射的ZnS纳米生物共轭物有望成为一种有效的,靶标特异性的荧光团,能够对临床组织上的任何目标抗原进行长期IF标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号